Perturbations in serum AMH are linked to a variety of pathological conditions, for instance, polycystic ovary syndrome and adult granulosa cell tumours; and it can be used as a tumour marker to gauge response to therapy and monitor recurrence [21]. This evidence concerns the gene AMH and polycystic ovary syndrome.